Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China

Y Lu, H Zhang, J Lu, Q Ding, X Li, X Wang… - JAMA network …, 2021 - jamanetwork.com
Importance Dyslipidemia, the prevalence of which historically has been low in China, is
emerging as the second leading yet often unaddressed factor associated with the risk of …

Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study

L Xing, L Jing, Y Tian, H Yan, B Zhang, Q Sun… - Nutrition, Metabolism …, 2020 - Elsevier
Background and aims Management of dyslipidemia remains the cornerstone for prevention
of cardiovascular diseases. We aimed to evaluate the epidemiology of dyslipidemia in …

Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults

M Zhang, Q Deng, L Wang, Z Huang, M Zhou… - International journal of …, 2018 - Elsevier
Background Elevated serum total cholesterol and low-density lipoprotein cholesterol (LDL-
C) levels are established risk factors for cardiovascular diseases, a leading cause of death …

[HTML][HTML] Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control

Y Huang, L Gao, X Xie, SC Tan - Population health metrics, 2014 - Springer
Background Numerous epidemiology studies on dyslipidemia have been conducted in
China. However, a nationally representative estimate for dyslipidemia prevalence is lacking …

[HTML][HTML] The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey

FL Zhang, YQ Xing, YH Wu, HY Liu, Y Luo… - Lipids in health and …, 2017 - Springer
Background Dyslipidemia is an important independent modifiable risk factor for
cardiovascular disease. The aim of this study was to explore the current prevalence …

[HTML][HTML] Awareness, treatment, control, and determinants of dyslipidemia among adults in China

S Opoku, Y Gan, EA Yobo, D Tenkorang-Twum… - Scientific Reports, 2021 - nature.com
Effective management of dyslipidemia is important. This study aimed to determine the
awareness, treatment, control, and determinants of dyslipidemia in middle-aged and older …

Dyslipidemia prevalence, treatment, control, and awareness in the Canadian Health Measures Survey

M Joffres, M Shields, MS Tremblay… - Canadian journal of public …, 2013 - Springer
Abstract Background The most recent Canadian population-level data on lipid levels are
from 1992. This study presents current estimates of Canadians with dyslipidemia, the …

[HTML][HTML] Prevalence and associated factors of dyslipidemia in the adult Chinese population

S Wang, L Xu, JB Jonas, QS You, YX Wang, H Yang - PloS one, 2011 - journals.plos.org
To determine the prevalence, associated factors, awareness and control of dyslipidemia in
Chinese living in Greater Beijing, we measured the serum cholesterol concentration in 3251 …

[HTML][HTML] Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project …

S Opoku, Y Gan, W Fu, D Chen, E Addo-Yobo… - BMC public health, 2019 - Springer
Background Dyslipidemia is a modifiable risk factor for cardiovascular disease (CVD). We
investigated the prevalence and associated risk factors of dyslipidemia-raised total …

Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US …

ND Wong, D Young, Y Zhao, H Nguyen… - Journal of clinical …, 2016 - Elsevier
Background The 2013 American College of Cardiology/American Heart Association
Cholesterol Management Guideline identifies 4 statin-eligible groups:(1) known …